Perfil clínico e tumoral de pacientes submetidas a tratamento neoadjuvante de câncer de mama no Hospital Erasto Gaertner

Dagnoni, Carini; Macedo, Larissa Maria; Argenti, Cristiano; Januário, João Estevam Abelha; Almeida, Thais Abreu; Skare, N.

doi:10.5327/z201600040004rbm

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Sendo assim conclui-se que este estudo forneceu dados que demonstram a associação entre obesidade e câncer de mama, especialmente durante o período pós-menopausal, ficando evidente que o excesso de peso é um fator de risco para o surgimento da doença. Research, Society and Development, v. 9, n. 3, e62932385, 2020 (CC BY 4. Dagnoni et. al.…”

Section: Resultsunclassified

Associação prevalência e fatores de risco entre obesidade e câncer de mama

Silva¹,

Costa²,

Neto³

et al. 2020

RSD

View full text Add to dashboard Cite

In Brazil and worldwide, an increase in breast cancer rates every year, so obese individuals have a risk of 1.5 to 3.5 more likely to develop cancer and obesity is also a risk factor for other cancers. . This article aims to analyze the association, prevalence and risk factors between obesity and breast cancer. This is an integrative literature review conducted through the databases of the Virtual Health Library (VHL), Scientific Electronic Library Online (SCIELO) and Latin American and Caribbean Health Sciences Literature (LILACS). After selecting twenty articles, only seven were part of the final sample. According to the results obtained, in the association between breast cancer and obesity, it was found in most studies that these are directly interconnected, which present pre-obesity and general obesity among women with breast cancer. Such results are closely linked to women undergoing postmenopausal treatment. Regarding prevalence, it is high among the population studied, risk factors indicate sedentary lifestyle, low physical activity and low knowledge about its benefits. The present study is limited to the association prevalence and risk factors between obesity and breast cancer. Given the above is evident the importance of studies such as these, since they contribute directly to scholars in the area, as well as to the literature.

show abstract

Section: Resultsunclassified

Associação prevalência e fatores de risco entre obesidade e câncer de mama

Silva¹,

Costa²,

Neto³

et al. 2020

RSD

View full text Add to dashboard Cite

show abstract

“…Dagnoni et al, in a retrospective study with 135 women, found that 123 patients underwent surgery, where 71 (52.59%) had a quadrantectomy and in 52 (38.51%) a mastectomy 22 . This is in line with the results of the present study with 192 patients, where 112 (58.33%) underwent mastectomy and 42 (21.87%) quadrantectomy.…”

Section: Discussionmentioning

confidence: 99%

Five-year retrospective study of HER2+ breast cancer in a referral hospital in the state of Amazonas

Silva,

Pereira,

Moraes

et al. 2023

Mastology

View full text Add to dashboard Cite

Introduction: Breast carcinoma is considered the most common malignancy in women, with a high incidence in Brazil and in the North region, surpassed only by non-melanoma skin cancer and cervical cancer. The HER2+ molecular subtype tends to grow and spread more quickly than other subtypes, resulting in the second worst outcome, behind only the triple-negative subtype. Methods: This was a retrospective, descriptive epidemiological study, using data from the medical records of 192 patients with HER2+ breast cancer treated at the Fundação Centro de Controle de Oncologia do Amazonas (FCECON), from 2014 to 2018. Results: The mean age of patients was 52±12 years. The predominant origin was Manaus. AM (53.1%). The most common education level was complete secondary education (36.5%) and the occupation was self-employed (37%). Most diagnoses were made in 2014 (23.4%). Regarding staging, the most common ones were stages IIIA and IIIB, both 20.83%. Concerning treatment, all patients (100%) underwent radiotherapy and chemotherapy, and surgery in 80.2%, including mastectomy (58.33%) and quadrantectomy (21.87%). Local recurrence and distant metastasis were both found in 7.3% of patients. With respect to the outcome, patients in follow-up predominated (53.6%), while mortality rate was 0.5%. Conclusions: The series demonstrated that patients with HER2 breast cancer present advanced staging and undergo neoadjuvant chemotherapy and surgery. The center in the present study is an institution that receives patients from several municipalities in the countryside of Amazonas and other states, and thus, many patients with advanced stages are cared for, since many such cities have no resources to perform mammography, compromising screening.

show abstract

Association of Magnetic Resonance and Tumor Markers in Patients Submitted to Neoadjunct Treatment of Breast Cancer: An Integrative Review

Coelho¹,

Silva²,

Silva³

2022

JHT

View full text Add to dashboard Cite

O câncer de mama é o tipo de câncer que mais afeta as mulheres em todo o mundo. No Brasil, essa neoplasia é responsável por 28% dos novos casos anuais de câncer, estima-se que uma em cada dez mulheres desenvolverá essa patologia ao longo da vida e em 2021 a incidência foi de 66.280 casos e cerca de 18.068 óbitos, caracterizando-se como bem como um importante problema de saúde pública entre as mulheres. Assim, este estudo tem como objetivo geral elencar a importância da ressonância magnética e dos marcadores tumorais no prognóstico e estadiamento de pacientes submetidas ao tratamento neoadjuvante do câncer de mama. Para tanto, foi realizada revisão integrativa da literatura, utilizando as seguintes bases de dados: SciELO, PubMed e BVS, além de busca de dados epidemiológicos nos sites do INCA e DATASUS. foram verificados, nos estudos analisados que a ressonância magnética é eficiente em fazer a avaliação após a terapia neoadjuvante, dependendo do subtipo de câncer de mama. O uso de contraste pode aumentar a eficácia da RM ao realçar os tecidos mamários normais e o parênquima mamário (BPE). A precisão da ressonância magnética varia de acordo com o subtipo de câncer de mama e a morfologia do tumor, sendo mais precisa na avaliação de tumores HER 2 positivos e triplo negativos. Os principais biomarcadores citados foram receptor de estrogênio (ER), receptor de progesterona (PR), HER2, Ki67, CA 12,5 e CA 19,9.

show abstract

Perfil clínico e tumoral de pacientes submetidas a tratamento neoadjuvante de câncer de mama no Hospital Erasto Gaertner

Cited by 3 publications

References 0 publications

Associação prevalência e fatores de risco entre obesidade e câncer de mama

Associação prevalência e fatores de risco entre obesidade e câncer de mama

Five-year retrospective study of HER2+ breast cancer in a referral hospital in the state of Amazonas

Association of Magnetic Resonance and Tumor Markers in Patients Submitted to Neoadjunct Treatment of Breast Cancer: An Integrative Review

Contact Info

Product

Resources

About